Jamieson Wellness: A Healthy Addition to Your Portfolio?

Jamieson stock was on a roll until the last year or so, but now offers a major deal for investors to consider, plus a shiny dividend.

Investment opportunities abound in the current market, as many stocks are trading at valuations far below fair value. Some of those companies even remain undervalued despite years of consistent performance. And one of those companies is Jamieson Wellness (TSX: JWEL).

Jamieson stock has been an excellent choice for Canadian investors when seeking out long-term income and steady growth. With attractive valuations, and more growth ahead, let’s look at why investors may want to consider adding it to their porfolio.

money while you sleep

Image source: Getty Images

Strong financial performance

During Jamieson stock’s most recent first quarter earnings report, investors were pleased to see a quarter that beat out earnings estimates. Consolidated revenue increased 31.9% for the company, with Jamieson Brands increasing 30%. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) increased to $24.5 million, with diluted earnings per share to $0.21.

Revenue grew faster than adjusted EBITDA for the quarter, registering a 17% increase. Management stated this was from strategic investments to build out their brand, expanding operations in both the United States and China. The natural health product maker is now confident its outlook for the year will continue to climb. In fact, the company already overdelivered on revenue expectations in the U.S. with stronger than expected consumption.

“Jamieson Wellness entered 2023 in a position of strength, having laid a solid foundation for continued growth across our business in 2022. Our Jamieson Brands segment delivered another exceptional quarter with a 30% revenue increase, reflecting organic growth, the impact of our U.S. acquisition, and the continued demand for our brands, globally.”

Mike Pilato, President and CEO of Jamieson Wellness

History repeating itself?

This latest growth comes as merely the latest in the company’s years of impressive financial growth. Between 2010 and 2020 alone, revenue increased from $206 million to $363 million, bringing in a remarkable compound annual growth rate (CAGR) of 6.5%. As you can see, Jamieson stock has already outpaced this growth in 2023 alone, as it continues to capture a larger market share.

As the company continues to expand around the world, it has enjoyed a significant amount of growth in the last decade, both organically and through strategic acquisitions. This includes acquisitions such as Body Plus in 2014, and the expansion into China, growing even faster since lockdowns lifted.

Yet shares of Jamieson stock are still down about 20% in the last year, and 13% in the last three months. So what should investors do now?

Consider the long run

Jamieson stock is actually quite new in terms of its time on the market. Since its initial public offering (IPO) in 2017, shares of the stock are up 54% as of writing. There was a surge as investors looked for growth stocks, but the stock has come down in recent years.

Now, the stock is an undervalued gem that investors shouldn’t miss out on. Being in the healthcare sector offers protection should the market drop once again. It also offers growth as its healthcare and beauty options bring in more consumers than ever before.

Jamieson stock offers a 2.36% dividend yield at the time of writing, trading at 23.7 times earnings. This is lower than the average five years, when the price-to-earnings (P/E) ratio sat around 25.6. So investors can lock in a deal, growth, and income from this undervalued stock. But only while it lasts.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

voice-recognition-talking-to-a-smartphone
Dividend Stocks

BCE Just Reported: What $10,000 Could Earn You in Dividends Today

BCE is yielding a very generous 5.2%, as the company's telecom business improves and long-term investments drive growth.

Read more »

Transparent umbrella under heavy rain against water drops splash background. Rainy weather concept.
Dividend Stocks

Is Intact’s Rough Quarter a Blip or the New Normal for Canadian Insurers?

Intact reported $660 million in pre-tax catastrophe losses during the quarter, which dragged its net operating income per share lower.

Read more »

investor faces bear market
Dividend Stocks

How Much to Invest in BCE for $1,500 a Year in Dividends

BCE (TSX:BCE) could be a huge dividend value winner as the stock markets correct and potentially flirt with a bear…

Read more »

diversification is an important part of building a stable portfolio
Dividend Stocks

Want $6,000 a Year From Your TFSA? Here’s the Portfolio Size to Aim for

A $150,000 starting target can support a $6,000 annual TFSA income goal without requiring an extreme yield.

Read more »

top TSX stocks to buy
Dividend Stocks

Hot Take: The Best Monthly Dividend Stock on the TSX Right Now

For investors seeking monthly dividend payments, this REIT has a history of consistent dividend payments across different market conditions, along…

Read more »

An investor uses a tablet
Dividend Stocks

Dividend Income vs. Selling Shares: Which Strategy Generates Better Cash Flow?

You might make more money periodically selling stock than you'd make collecting Fortis Inc (TSX:FTS) dividends.

Read more »

money goes up and down in balance
Dividend Stocks

How Much to Invest in This TSX Stock for $750 a Quarter in Dividends

Want $750 a quarter? Alaris pays $1.56 a year at $21.54. See how many units to buy, what Q3 showed,…

Read more »

Pile of Canadian dollar bills in various denominations
Dividend Stocks

Fortis Unveils Its Biggest Spending Plan Ever: $32.2 Billion for Power and Gas Projects

Fortis has unveiled its largest-ever $32.2 billion investment plan, which could support long-term earnings growth and higher dividends for shareholders.

Read more »